Improving the cellular pertussis vaccine: Increased potency and consistency

Vaccine

Volumn 26, Issue 5, 2008, Pages 653-663

  Thalen, Marcel ^a   van der Ark, Arno ^b   van den IJssel, Jan ^b   van Straaten, Ineke ^b   Jansen, Dennis ^b   Beuvery, Coen ^c   Martens, Dirk ^d   Tramper, Johannes ^d  

^a SynCo Bio Partners   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^c PAT Consultancy ^*  (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Cellular pertussis vaccine; Consistency; Production process

Indexed keywords

ANTIGEN; PERTUSSIS VACCINE;

ANIMAL MODEL; ARTICLE; CANADA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EUROPE; IMMUNOGENICITY; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; UNITED STATES;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CULTURE MEDIA; DRUG EVALUATION, PRECLINICAL; INJECTIONS, INTRAPERITONEAL; MICE; PERTUSSIS VACCINE; VACCINES, INACTIVATED; WHOOPING COUGH;

EID: 37849014245     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.047     Document Type: Article

References (18)

1. Olin P., Rasmussen F., Hallander H.O., and Heijbel H. Randomised controlled trial of two-component, three-component, and five-component aceullular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 350 (1997) 1569-1577
2. Edwards K.M., Meade B.D., Decker M.D., Reed G.F., Rennels M.B., Steinhoff M.C., et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96 Suppl. (1995) 548-557
3. Csizer Z., Szammet A., Niedermayer N., Zsidai F., Auber E., and Foo I. Estimation of bacterial mass of pertussis vaccine by opacity and dry weight determinations. J Biol Stand 5 4 (1977) 289-295
4. Thalen M., Venema M., van den IJssel J., Berwald L., Beuvery E.C., Martens D.E., et al. Effect of relevant culture parameters on pertussis toxin expression by Bordetella pertussis. Biologicals 34 3 (2006) 213-220
5. Kendrick P.L., Eldering G., Dixson M.K., and Misner J. Mouse protection tests in the study of pertussis vaccines: a comparative series using intracerebral route of challenge. Am J Public Health 37 (1947) 803-810
6. van Hemert P.A. Specific properties of acid precipitated pertussis vaccines. Prog Immunobiol Stand 3 (1969) 297-301
7. Verweij W.F., Thiele E.H., Sage D.N., and Schuchardt L.F. A simplified liquid culture medium for the growth of Hemophilus pertussis. J Bacteriol 58 (1949) 127
8. Dorresteijn R.C., Berwald L.G., Zomer G., De Gooijer C.D., Wieten G., and Beuvery E.C. The determination of amino acids using O-phthalaldehyde/2-mercaptoethanol derivatization: effect of reaction conditions. J Chromatogr B 724 (1996) 159-167
9. vd Ark A., v Straaten-vd Kappelle I., Akkermans A., Hendriksen C., and vd Donk H. Development of pertussis serological potency test: serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model. Biologicals 22 (1994) 233-242
10. Thalen M., van den IJssel J., Jiskoot W., Zomer B., Roholl P., de Gooijer C.D., et al. Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol 75 (1999) 147-159
11. Caroff M., Caroff M., Deprun C., Richards J.C., and Karibian D. Structural characterization of the lipid A of B. pertussis 1414 endotoxin. J Bacteriol 179 (1994) 5156-5159
12. Stanier D.W., and Scholte M.J. A simple chemically defined medium for the production of phase I B. pertussis. J Gen Microbiol 63 (1971) 211-220
13. Neeleman R., Joerink M., Beuvery C., and van Boxtel T. Dual-substrate utilization by Bordetella pertussis. Appl Microbiol Biotechnol 57 4 (2001) 489-493
14. Cyr T., Menzies A.J., Calver J., and Whitehouse L.W. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole-cell and acellular pertussis vaccine products. Biologicals 29 (2001) 81-95
15. Means G.E., and Feeney R.E. Chemical modifications of proteins (1971), Holden-Day Inc., New York
16. Gottshall R.Y., Nelson E., Angela F., and Anderson G. The effect of formaldehyde on the toxicity and potency of pertussis vaccine. Health Lab Sci 12 (1975) 35-40
17. Westdijk J., van den IJssel J., Thalen M., Beuvery C., and Jiskoot W. Quantification of cell-associated and free antigens in B. pertussis suspensions by antigen binding ELISA. J Immunoassay 18 3 (1997) 267-284
18. Ph Eur, Monograph 2005:0161 (2.7.7).